JMPWA
PNT

JP Morgan Private Wealth Advisors’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio PNT Stock Details PNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$133K Hold
20,000
– – ﹤0.01% 1668
2023
Q2 		$181K Buy
20,000
+5,000
+33% +$44.1K ﹤0.01% 1403
2023
Q1 		$109K Buy
+15,000
New +$111K ﹤0.01% 1895

Other funds holding PNT

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Private Wealth Advisors's PNT Position: Q3 2023 in Review

JP Morgan Private Wealth Advisors held its POINT Biopharma Global Inc. Common Stock (PNT) position steady in Q3 2023 at 20,000 shares worth $133K. The position accounts for ﹤0.01% of the portfolio, ranked #1668.

JP Morgan Private Wealth Advisors first reported a position in PNT in Q1 2023 and has held it in 3 quarters since. The position peaked at $181K in Q2 2023. 125 funds tracked by Wall St. Rank hold PNT as of Q3 2023.

  • JP Morgan Private Wealth Advisors held 20,000 shares of POINT Biopharma Global Inc. Common Stock worth $133K as of Q3 2023.
  • JP Morgan Private Wealth Advisors left its POINT Biopharma Global Inc. Common Stock share count unchanged in Q3 2023.
  • POINT Biopharma Global Inc. Common Stock made up ﹤0.01% of JP Morgan Private Wealth Advisors's portfolio in Q3 2023, its #1668 holding.
  • JP Morgan Private Wealth Advisors first reported a position in POINT Biopharma Global Inc. Common Stock in Q1 2023 and has held it in 3 quarters since.
  • JP Morgan Private Wealth Advisors's POINT Biopharma Global Inc. Common Stock position peaked at $181K in Q2 2023.
  • 125 funds tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q3 2023.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.